Reply of the Authors: CA-125 as a biomarker for malignant transformation of endometriosis
Open accessIntegrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CA-125 is not specific for endometriosis, being a tumor marker elevated in ovarian cancer.
“However, CA-125 is not specific for endometriosis, being a tumor marker elevated in ovarian cancer [37, 38].”
From Update on biomarkers for the detection of endometriosis (2015) · cites this paper as [37]
Cites
Malignancy in Endometriosis: Frequency and Comparison of Ovarian and Extraovarian Types
Stern, R. C., Dash, R., Bentley, R. C., Snyder, M. J., Haney, A. F., & Robboy, S. J. (2001) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200104000-00004 · Cited by 403 · see citing works
The relationship of endometriosis and ovarian malignancy: a review
Nezhat, F. R., Datta, M., Hanson, V., Pejovic, T. B., Nezhat, C., & NEZHAT, C. R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.007 · Cited by 246 · see citing works
Self-citationStage I ovarian carcinoma: different clinical pathologic patterns
Deligdisch, L., Penault-Llorca, F. M., Schlosshauer, P. W., Altchek, A., Peiretti, M., & Nezhat, F. R. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.035 · Cited by 48 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Update on biomarkers for the detection of endometriosis
Fassbender, A., Burney, R. O., F. O, D., D’Hooghe, T., & Giudice, L. (2015) · BioMed Research International · doi:10.1155/2015/130854 · Cited by 195 · see citing works
“However, CA-125 is not specific for endometriosis, being a tumor marker elevated in ovarian cancer [37, 38].”
- Authors
- Nezhat, F.
- Affiliations
- St. Luke's-Roosevelt Hospital Center (US)
- Corresponding author
- Nezhat, Farr
- ORCID
- Nezhat, Farr
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 91
- Issue
- 5
- Pages
- e36
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W1981122847
- Cited by
- 1
- References
- 3
- Citations by year
- 2015: 1
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- CA125, endometriosis, malignant transformation, endometrioma, ovarian cancer, clear cell carcinoma, endometrioid carcinoma, tumor markers, surveillance (medicine), surgical management, ovarian cancer screening, biomarkers, endometriosis-associated cancer risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
